Literature DB >> 10792376

The 19-kD antigen and protective immunity in a murine model of tuberculosis.

V V Yeremeev1, I V Lyadova, B V Nikonenko, A S Apt, C Abou-Zeid, J Inwald, D B Young.   

Abstract

The 19-kD antigen is a cell wall-associated lipoprotein present in Mycobacterium tuberculosis and in bacille Calmette-Guérin (BCG) vaccine strains. Expression of the 19-kD antigen as a recombinant protein in two saprophytic mycobacteria-M. vaccae and M. smegmatis-resulted in abrogation of their ability to confer protection against M. tuberculosis in a murine challenge model, and in their ability to prime a DTH response to cross-reactive mycobacterial antigens. Induction of an immune response to the 19-kD antigen by an alternative approach of DNA vaccination had no effect on subsequent M. tuberculosis challenge. These results are consistent with a model in which the presence of the 19-kD protein has a detrimental effect on the efficacy of vaccination with live mycobacteria. Targeted inactivation of genes encoding selected antigens represents a potential route towards development of improved vaccine candidates.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10792376      PMCID: PMC1905638          DOI: 10.1046/j.1365-2249.2000.01212.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  22 in total

Review 1.  Mycobacterial protein antigens: a compilation.

Authors:  D B Young; S H Kaufmann; P W Hermans; J E Thole
Journal:  Mol Microbiol       Date:  1992-01       Impact factor: 3.501

2.  Analysis of human T-cell epitopes in the 19,000 MW antigen of Mycobacterium tuberculosis: influence of HLA-DR.

Authors:  A Faith; C Moreno; R Lathigra; E Roman; M Fernandez; S Brett; D M Mitchell; J Ivanyi; A D Rees
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

3.  Specificity of antibodies to immunodominant mycobacterial antigens in pulmonary tuberculosis.

Authors:  P S Jackett; G H Bothamley; H V Batra; A Mistry; D B Young; J Ivanyi
Journal:  J Clin Microbiol       Date:  1988-11       Impact factor: 5.948

4.  Results of a World Health Organization-sponsored workshop to characterize antigens recognized by mycobacterium-specific monoclonal antibodies.

Authors: 
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

5.  T cell activation by antigen-presenting cells from lung tissue digests: suppression by endogenous macrophages.

Authors:  P G Holt; A Degebrodt; C O'Leary; K Krska; T Plozza
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

6.  Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells.

Authors:  D P Harris; H M Vordermeier; G Friscia; E Román; H M Surcel; G Pasvol; C Moreno; J Ivanyi
Journal:  J Immunol       Date:  1993-06-01       Impact factor: 5.422

7.  Transformation of mycobacterial species using hygromycin resistance as selectable marker.

Authors:  T R Garbe; J Barathi; S Barnini; Y Zhang; C Abou-Zeid; D Tang; R Mukherjee; D B Young
Journal:  Microbiology       Date:  1994-01       Impact factor: 2.777

8.  Genetic analysis of superoxide dismutase, the 23 kilodalton antigen of Mycobacterium tuberculosis.

Authors:  Y Zhang; R Lathigra; T Garbe; D Catty; D Young
Journal:  Mol Microbiol       Date:  1991-02       Impact factor: 3.501

9.  Expression of the Mycobacterium tuberculosis 19-kilodalton antigen in Mycobacterium smegmatis: immunological analysis and evidence of glycosylation.

Authors:  T Garbe; D Harris; M Vordermeier; R Lathigra; J Ivanyi; D Young
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

Review 10.  T cell response to Mycobacterium tuberculosis.

Authors:  I M Orme; P Andersen; W H Boom
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

View more
  20 in total

Review 1.  Effective vaccination against tuberculosis-a new ray of hope.

Authors:  J M Grange
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.

Authors:  Kris Huygen
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens.

Authors:  Pål Johansen; Antonia Fettelschoss; Beat Amstutz; Petra Selchow; Ying Waeckerle-Men; Peter Keller; Vojo Deretic; Leonhard Held; Thomas M Kündig; Erik C Böttger; Peter Sander
Journal:  Clin Vaccine Immunol       Date:  2011-04-06

4.  Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation.

Authors:  I S Leal; B Smedegård; P Andersen; R Appelberg
Journal:  Immunology       Date:  2001-10       Impact factor: 7.397

5.  Human leucocyte antigen-A2 restricted and Mycobacterium tuberculosis 19-kDa antigen-specific CD8+ T-cell responses are oligoclonal and exhibit a T-cell cytotoxic type 2 response cytokine-secretion pattern.

Authors:  H Höhn; C Kortsik; K Nilges; A Necker; K Freitag; G Tully; C Neukirch; M J Maeurer
Journal:  Immunology       Date:  2001-11       Impact factor: 7.397

6.  Impact of toll-like receptor 2 deficiency on immune responses to mycobacterial antigens.

Authors:  Muhammad J Rahman; Olga D Chuquimia; Dagbjort H Petursdottir; Natalia Periolo; Mahavir Singh; Carmen Fernández
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.441

Review 7.  Mycobacterium tuberculosis pathogenesis and molecular determinants of virulence.

Authors:  Issar Smith
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

8.  The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.

Authors:  Adam J Gehring; Roxana E Rojas; David H Canaday; David L Lakey; Clifford V Harding; W Henry Boom
Journal:  Infect Immun       Date:  2003-08       Impact factor: 3.441

9.  Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.

Authors:  D Neil Wedlock; Michel Denis; Gavin F Painter; Gary D Ainge; H Martin Vordermeier; R Glyn Hewinson; Bryce M Buddle
Journal:  Clin Vaccine Immunol       Date:  2008-03-12

10.  The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.

Authors:  Avi-Hai Hovav; Jacob Mullerad; Liuba Davidovitch; Yolanta Fishman; Fabiana Bigi; Angel Cataldi; Herve Bercovier
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.